Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Real-World Impact of Mepolizumab on the Oral Corticosteroid Freedom Component of Clinical Remission in Severe Eosinophilic Asthma: International, Prospective REALITI-A Study

Geoffrey Chupp,Liam Heaney, Rob Price,Guy Brusselle,Frances Gardiner, Alejandro Raimondi,Rekha Chaudhuri,Peter Howarth

Journal of Allergy and Clinical Immunology（2023）

Cited 0|Views21
No score
Abstract
Reducing/eliminating oral corticosteroids (OCS) burden is a main aim of severe asthma management; OCS freedom is a key criterion of clinical remission. Mepolizumab reduces clinically significant asthma exacerbations (CSEs) and maintenance OCS (mOCS) use in patients with severe eosinophilic asthma.
More
Translated text
Key words
severe eosinophilic asthma,oral corticosteroid freedom component,mepolizumab,real-world
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined